Aspirin with Low-Dose Ticagrelor or with Low-Dose Rivaroxaban for Secondary Prevention: A Cost per Outcome Analysis-Reference-Cited by-同舟云学术

Aspirin with Low-Dose Ticagrelor or with Low-Dose Rivaroxaban for Secondary Prevention: A Cost per Outcome Analysis

Published:2022-07-23 Issue:6 Volume:22 Page:677-683
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Tsaban Gal^ORCID,Alnsasra Hilmi,El Nasasra Aref,Abu-Salman Amjad,Abu-Dogosh Ala,Weissberg Itay,Golan Yael Ben-Baruch,Barrett Orit,Westreich Roi,Aboalhasan Enis,Azuri Joseph,Hammerman Ariel,Arbel Ronen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40256-022-00543-8.pdf

Reference18 articles.

1. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA J Am Med Assoc [Internet]. American Medical Association 2010;304:1350–7. https://jamanetwork.com/journals/jama/fullarticle/186626. Accessed 12 Oct 2021.

2. Capodanno D, Alberts M, Angiolillo DJ. Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease. Nat Rev Cardiol [Internet]. Nat Rev Cardiol 2016;13:609–22. https://pubmed.ncbi.nlm.nih.gov/27489191/. Accessed 12 Oct 2021.

3. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes: commentary. Rev Port Cardiol [Internet]. Massachusetts Medical Society 2007;26:1297–8. https://doi.org/10.1056/nejmoa0706482. Accessed 12 Oct 2021.

4. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med [Internet]. Massachusetts Medical Society 2009;361:1045–57. https://doi.org/10.1056/nejmoa0904327. Accessed 12 Oct 2021.

5. Investigators TC in UA to PRET. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without st-segment elevation. N Engl J Med [Internet]. Massachusetts Medical Society 2001;345:494–502. https://doi.org/10.1056/nejmoa010746. Accessed 12 Oct 2021.